307 related articles for article (PubMed ID: 25312961)
1. The chemokine (CCL2-CCR2) signaling axis mediates perineural invasion.
He S; He S; Chen CH; Deborde S; Bakst RL; Chernichenko N; McNamara WF; Lee SY; Barajas F; Yu Z; Al-Ahmadie HA; Wong RJ
Mol Cancer Res; 2015 Feb; 13(2):380-90. PubMed ID: 25312961
[TBL] [Abstract][Full Text] [Related]
2. Estrogen promotes progression of hormone-dependent breast cancer through CCL2-CCR2 axis by upregulation of Twist via PI3K/AKT/NF-κB signaling.
Han R; Gu S; Zhang Y; Luo A; Jing X; Zhao L; Zhao X; Zhang L
Sci Rep; 2018 Jun; 8(1):9575. PubMed ID: 29934505
[TBL] [Abstract][Full Text] [Related]
3. CCL2/CCR2 signaling elicits itch- and pain-like behavior in a murine model of allergic contact dermatitis.
Jiang H; Cui H; Wang T; Shimada SG; Sun R; Tan Z; Ma C; LaMotte RH
Brain Behav Immun; 2019 Aug; 80():464-473. PubMed ID: 30981714
[TBL] [Abstract][Full Text] [Related]
4. GFRα1 released by nerves enhances cancer cell perineural invasion through GDNF-RET signaling.
He S; Chen CH; Chernichenko N; He S; Bakst RL; Barajas F; Deborde S; Allen PJ; Vakiani E; Yu Z; Wong RJ
Proc Natl Acad Sci U S A; 2014 May; 111(19):E2008-17. PubMed ID: 24778213
[TBL] [Abstract][Full Text] [Related]
5. CCL2/CCR2 axis induces hepatocellular carcinoma invasion and epithelial-mesenchymal transition in vitro through activation of the Hedgehog pathway.
Zhuang H; Cao G; Kou C; Liu T
Oncol Rep; 2018 Jan; 39(1):21-30. PubMed ID: 29115520
[TBL] [Abstract][Full Text] [Related]
6. CCR2 signaling in breast carcinoma cells promotes tumor growth and invasion by promoting CCL2 and suppressing CD154 effects on the angiogenic and immune microenvironments.
Brummer G; Fang W; Smart C; Zinda B; Alissa N; Berkland C; Miller D; Cheng N
Oncogene; 2020 Mar; 39(11):2275-2289. PubMed ID: 31827233
[TBL] [Abstract][Full Text] [Related]
7. In vitro dorsal root ganglia and human prostate cell line interaction: redefining perineural invasion in prostate cancer.
Ayala GE; Wheeler TM; Shine HD; Schmelz M; Frolov A; Chakraborty S; Rowley D
Prostate; 2001 Nov; 49(3):213-23. PubMed ID: 11746267
[TBL] [Abstract][Full Text] [Related]
8. TR4 nuclear receptor promotes prostate cancer metastasis via upregulation of CCL2/CCR2 signaling.
Ding X; Yang DR; Lee SO; Chen YL; Xia L; Lin SJ; Yu S; Niu YJ; Li G; Chang C
Int J Cancer; 2015 Feb; 136(4):955-64. PubMed ID: 24975468
[TBL] [Abstract][Full Text] [Related]
9. Inflammatory Monocytes Promote Perineural Invasion via CCL2-Mediated Recruitment and Cathepsin B Expression.
Bakst RL; Xiong H; Chen CH; Deborde S; Lyubchik A; Zhou Y; He S; McNamara W; Lee SY; Olson OC; Leiner IM; Marcadis AR; Keith JW; Al-Ahmadie HA; Katabi N; Gil Z; Vakiani E; Joyce JA; Pamer E; Wong RJ
Cancer Res; 2017 Nov; 77(22):6400-6414. PubMed ID: 28951461
[TBL] [Abstract][Full Text] [Related]
10. Chemokine Signaling Facilitates Early-Stage Breast Cancer Survival and Invasion through Fibroblast-Dependent Mechanisms.
Brummer G; Acevedo DS; Hu Q; Portsche M; Fang WB; Yao M; Zinda B; Myers M; Alvarez N; Fields P; Hong Y; Behbod F; Cheng N
Mol Cancer Res; 2018 Feb; 16(2):296-308. PubMed ID: 29133591
[TBL] [Abstract][Full Text] [Related]
11. Autocrine CCL2 promotes cell migration and invasion via PKC activation and tyrosine phosphorylation of paxillin in bladder cancer cells.
Chiu HY; Sun KH; Chen SY; Wang HH; Lee MY; Tsou YC; Jwo SC; Sun GH; Tang SJ
Cytokine; 2012 Aug; 59(2):423-32. PubMed ID: 22617682
[TBL] [Abstract][Full Text] [Related]
12. Contribution of chemokine CCL2/CCR2 signaling in the dorsal root ganglion and spinal cord to the maintenance of neuropathic pain in a rat model of lumbar disc herniation.
Zhu X; Cao S; Zhu MD; Liu JQ; Chen JJ; Gao YJ
J Pain; 2014 May; 15(5):516-26. PubMed ID: 24462503
[TBL] [Abstract][Full Text] [Related]
13. CCL2 facilitates spinal synaptic transmission and pain via interaction with presynaptic CCR2 in spinal nociceptor terminals.
Ma SB; Xian H; Wu WB; Ma SY; Liu YK; Liang YT; Guo H; Kang JJ; Liu YY; Zhang H; Wu SX; Luo C; Xie RG
Mol Brain; 2020 Nov; 13(1):161. PubMed ID: 33228784
[TBL] [Abstract][Full Text] [Related]
14. Recruitment of γδ T cells to the lesion via the CCL2/CCR2 signaling after spinal cord injury.
Xu P; Zhang F; Chang MM; Zhong C; Sun CH; Zhu HR; Yao JC; Li ZZ; Li ST; Zhang WC; Sun GD
J Neuroinflammation; 2021 Mar; 18(1):64. PubMed ID: 33653377
[TBL] [Abstract][Full Text] [Related]
15. CCL2 Mediates Neuron-Macrophage Interactions to Drive Proregenerative Macrophage Activation Following Preconditioning Injury.
Kwon MJ; Shin HY; Cui Y; Kim H; Thi AH; Choi JY; Kim EY; Hwang DH; Kim BG
J Neurosci; 2015 Dec; 35(48):15934-47. PubMed ID: 26631474
[TBL] [Abstract][Full Text] [Related]
16. Targeting of tumour-infiltrating macrophages via CCL2/CCR2 signalling as a therapeutic strategy against hepatocellular carcinoma.
Li X; Yao W; Yuan Y; Chen P; Li B; Li J; Chu R; Song H; Xie D; Jiang X; Wang H
Gut; 2017 Jan; 66(1):157-167. PubMed ID: 26452628
[TBL] [Abstract][Full Text] [Related]
17. Tumor-derived CXCL8 signaling augments stroma-derived CCL2-promoted proliferation and CXCL12-mediated invasion of PTEN-deficient prostate cancer cells.
Maxwell PJ; Neisen J; Messenger J; Waugh DJ
Oncotarget; 2014 Jul; 5(13):4895-908. PubMed ID: 24970800
[TBL] [Abstract][Full Text] [Related]
18. Targeting the androgen receptor with siRNA promotes prostate cancer metastasis through enhanced macrophage recruitment via CCL2/CCR2-induced STAT3 activation.
Izumi K; Fang LY; Mizokami A; Namiki M; Li L; Lin WJ; Chang C
EMBO Mol Med; 2013 Sep; 5(9):1383-401. PubMed ID: 23982944
[TBL] [Abstract][Full Text] [Related]
19. Regulation of growth, invasion and metabolism of breast ductal carcinoma through CCL2/CCR2 signaling interactions with MET receptor tyrosine kinases.
Acevedo DS; Fang WB; Rao V; Penmetcha V; Leyva H; Acosta G; Cote P; Brodine R; Swerdlow R; Tan L; Lorenzi PL; Cheng N
Neoplasia; 2022 Jun; 28():100791. PubMed ID: 35405500
[TBL] [Abstract][Full Text] [Related]
20. CCL2-CCR2 axis promotes metastasis of nasopharyngeal carcinoma by activating ERK1/2-MMP2/9 pathway.
Yang J; Lv X; Chen J; Xie C; Xia W; Jiang C; Zeng T; Ye Y; Ke L; Yu Y; Liang H; Guan XY; Guo X; Xiang Y
Oncotarget; 2016 Mar; 7(13):15632-47. PubMed ID: 26701209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
